Skip to main content
graph.swiss
SKAN Group AG

SKAN Group AG

56.30 CHF-2.20 (-3.76%)
XSWX:SKANMarket Closed
ListedCHF1.3BHealthcareMedical Instruments & Supplies1,557 employees

Company Profile

Legal NameSKAN Group AG
CEOMr. Thomas Huber
HeadquartersKreuzstrasse 5
Phone41 61 485 44 44
Employees (FTE)1,557
SectorHealthcare
IndustryMedical Instruments & Supplies

Business Description

SKAN Group AG is a Swiss-based company and global market leader in developing and manufacturing isolators, cleanroom devices, and decontamination processes for aseptic production in the pharmaceutical and chemical industries. Operating through two main segments—Equipment and Solutions, and Services and Consumables—it provides advanced products including isolators, laminar flow systems, safety workbenches, transfer systems, fume cupboards, biological indicators, and personal protective equipment, alongside digital solutions, lifecycle support, and laboratory services. Founded in 1968 and headquartered in Allschwil, Switzerland, with over 1,600 employees across subsidiaries in Europe, the Americas, Asia, and beyond, SKAN Group AG serves high-regulatory markets like Europe, North America, Japan, and emerging regions such as China and India. Renowned for its expertise in ventilation, sterilization, validated software, microbiology, and regulatory compliance, the company supports blue-chip biopharmaceutical firms and research labs, contributing significantly to processes like vaccine filling—every third vaccine in core markets uses SKAN isolators—and maintains high market entry barriers through innovation and comprehensive lifecycle partnerships. Its commitment to precision engineering and quality positions it as a key player in the healthcare equipment sector, particularly advanced medical technology for sterile manufacturing.

Profitability & Growth

Profitability

Profit Margin+4.88%
Operating Margin+15.26%
Return on Equity (TTM)+10.64%
Return on Assets (TTM)+3.67%

Recent Year-End

Revenue333.3M
Revenue / Share14.83
Gross Profit249.7M
EBITDA35.5M
Diluted EPS0.72
Earnings Growth YoY+0.40%
Revenue Growth YoY+0.60%

Balance Sheet Snapshot

Total Cash (MRQ)

94.1M

Total Debt (MRQ)

131.5M

Current Ratio (MRQ)

1.31

Book Value / Share

5.09

Stock Statistics

Shares Outstanding22.5M
Float Shares12.7M
Avg Volume (10d)17.2K
Avg Volume (90d)19.4K
% Held by Insiders+43.50%
% Held by Institutions+26.69%

Valuation

Market Cap1.27B
Enterprise Value1.33B
Trailing P/E79.31
Forward P/E32.18
PEG Ratio32.18
Price / Sales (TTM)3.85
Price / Book (MRQ)11.22
EV / Revenue4.00
EV / EBITDA37.61

Price Summary

52-Week Low35.75
52-Week High77.80
50-Day MA50.92
200-Day MA50.91
Beta0.74

Dividends

Forward Div Rate0.88
Forward Div Yield+1.56%
Trailing Div Rate0.22
Payout Ratio+55.56%
Dividend Date2025-05-13
Ex-Dividend Date2026-05-11